Rhopressa (soln)

Rhopressa (soln)

Generic: netarsudil dimesylate 0.02%

Rhopressa (soln)
DOSAGE 1 gtt QPM
GENERIC netarsudil dimesylate 0.02%
SIZE 2.5mL
INDICATIONS Reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.
MECHANISM OF ACTION Increase aqueous outflow
MICROBIOLOGY Netarsudil is a rho kinase inhibitor, which is believed to reduce IOP by increasing the outflow of aqueous humor through the trabecular meshwork. The exact mechanism is unknown.
CONTRAINDICATIONS & WARNINGS None
PEDIATRIC USE Safety and effectiveness in pediatric patients below the age of 18 years have not been established.
PREGNANCY There are no available data on RHOPRESSA use in pregnant women to inform any drug associated risk; however, systemic exposure to netarsudil from ocular administration is low
NOTE